Multiparametric Flow Cytometry in the Evaluation of Plasma Cell Proliferative Disorders: Current Paradigms for Clinical Practice
Authors:
- 27 November 2023
- journal article
- review article
- Published by Elsevier in Clinical Lymphoma Myeloma and Leukemia
- Vol. 24 (3) , e88-e95
Abstract
No abstract availableKeywords
Funding Information
- Indian Council of Medical Research
This publication has 73 references indexed in Scilit:
- Long-term survival in multiple myeloma is associated with a distinct immunological profile, which includes proliferative cytotoxic T-cell clones and a favourable Treg/Th17 balanceBlood Cancer Journal, 2013
- High levels of peripheral blood circulating plasma cells as a specific risk factor for progression of smoldering multiple myelomaLeukemia, 2012
- Circulating plasma cells predict the outcome of relapsed or refractory multiple myelomaLeukemia & Lymphoma, 2012
- CD28 Expressed on Malignant Plasma Cells Induces a Prosurvival and Immunosuppressive MicroenvironmentThe Journal of Immunology, 2011
- Significantly reduced regulatory T cell population in patients with untreated multiple myelomaLeukemia Research, 2011
- Proliferation is a central independent prognostic factor and target for personalized and risk-adapted treatment in multiple myelomaHaematologica, 2010
- Risk of progression in smouldering myeloma and monoclonal gammopathies of unknown significance: comparative analysis of the evolution of monoclonal component and multiparameter flow cytometry of bone marrow plasma cellsBritish Journal of Haematology, 2009
- Flow Cytometric Immunophenotyping and Minimal Residual Disease Analysis in Multiple MyelomaAmerican Journal of Clinical Pathology, 2009
- Prognostic Value of Immunophenotyping in Multiple Myeloma: A Study by the PETHEMA/GEM Cooperative Study Groups on Patients Uniformly Treated With High-Dose TherapyJournal of Clinical Oncology, 2008
- Prognostic Value of Circulating Plasma Cells in Monoclonal Gammopathy of Undetermined SignificanceJournal of Clinical Oncology, 2005